How big is Eton Pharmaceuticals, Inc.?

Jun 22 2025 06:12 PM IST
share
Share Via
As of Jun 18, Eton Pharmaceuticals, Inc. has a market capitalization of 364.99 million and reported net sales of 48.32 million with a net profit of -4.58 million over the last four quarters. Shareholder's funds are 24.43 million, and total assets are 76.12 million as of Dec 24.
As of Jun 18, Eton Pharmaceuticals, Inc. has a market capitalization of 364.99 million, categorizing it as a Micro Cap company.

As of Jun 18, the sum of net sales for the latest four quarters is 48.32 million, while the sum of net profit for the same period is -4.58 million.

As of Dec 24, the shareholder's funds amount to 24.43 million, and total assets are reported at 76.12 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Eton Pharmaceuticals, Inc. overvalued or undervalued?
Sep 20 2025 06:35 PM IST
share
Share Via
Is Eton Pharmaceuticals, Inc. overvalued or undervalued?
Jun 25 2025 09:16 AM IST
share
Share Via
What does Eton Pharmaceuticals, Inc. do?
Jun 22 2025 06:59 PM IST
share
Share Via